PATENT CLAIM ANALYSIS

Application Number: 15779829
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "560000"]

Abstract:
The invention relates to lipid compounds of formula (I) and their pharmaceutically acceptable salts for the prevention and/or treatment of ophthalmic disorders such as retinal degenerative disorders and ocular inflammatory diseases: (I) (wherein R 1  is either a C 9  to C 22  alkyl group, or a C 9  to C 22  alkenyl group having from 1 to 6 double bonds; R 2  is selected from the group consisting of a halogen atom, a hydroxy group, an alkyl group, an alkoxy group, an alkylthio group, a carboxy group, an acyl group, an amino group, and an alkylamino group; R 3  is a hydrogen atom, or a group R 2 ; R 4  is a carboxylic acid or a derivative thereof; and X is methylene (—CH 2 —), or an oxygen or sulfur atom).

Claim (Index 22):
A lipid compound for use as claimed in any one of  claims 17  to  21 , wherein at least two double bonds are present in group R 1 , preferably wherein at least one pair of successive double bonds is interrupted by no more than one methylene group, e.g. wherein each pair of consecutive double bonds is interrupted by no more than one methylene group.

Metadata:
- Claim Count in Document: 69.0
- Percentile: 93.0
- Lexical Diversity: 2.01282
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13054212', '12293966', '12446615', '12741890', '13319101']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7843542233301414
- 35 USC 102 Novelty (BERT): 0.5210798987445052
- Combined Prediction Score: 0.7580267908715778
- Mean Citation Score: 278.36449600000003
- Max Citation Score: 309.60422
- Similarity Product: 209.47031062674048

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test